Feeling ill after traveling
Conditions
Interventions
Group 1: This is a monocentric, prospective study in which volunteers returning from travel with respiratory infections and/or fever are recruited. After receiving information about the study and givi
Sponsors
Universitätsklinikum Frankfurt, Institut für medizinische Virologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults over the age of 18 who are capable of giving consent and who have respiratory symptoms and/or fever and/or new skin rashes after traveling outside Europe. Return from a trip to destinations outside the European Union. Symptoms must have started during the trip or no later than 48 hours after return.
Exclusion criteria
Exclusion criteria: Patients under 18 years of age Incapacity to give consent (e.g., due to language barriers or cognitive impairments) Taking oseltamivir/baloxavir since the onset of illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the prevalence of infections with the potential for epidemic spreading in a cohort of up to 1,000 symptomatic travelers returning from abroad. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of pan-negative POCT and rapid antigen tests and metagenomic sequencing results in pan-negative rapid tests. Number of co-infections in rapid respiratory tests. Virological characteristics of virus isolates with sequence differences from strains circulating here. | — |
Countries
Germany
Contacts
Public ContactSandra Ciesek
Universitätsmedizin Frankfurt, Institut für medizinische Virologie
Outcome results
None listed